A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers

NCT05363592 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CT-L01 12.5/500 mg
DRUG: Alogliptin Benzoate 12.5 mg
DRUG: Metformin HCl XR 500 mg

Sponsor

Celltrion